Ratings Bushveld Minerals Limited

Equities

BMN

GG00B4TM3943

Delayed London S.E. Other stock markets 05:58:09 2024-05-02 EDT			5-day change	1st Jan Change
0.732 ^GBX	+4.57%		+10.91%	-65.14%

04-29	Transcript : Bushveld Minerals Limited, Q1 2024 Operating Results Call, Apr 29, 2024
04-23	EARNINGS AND TRADING: Graft Polymer extends loan; ASA profit down 30%	AN

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

The company shows low valuation levels, with an enterprise value at 0.6 times its sales.
Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
For the past twelve months, EPS forecast has been revised upwards.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

Low profitability weakens the company.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Uranium

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
BUSHVELD MINERALS LIMITED	-65.14%	18.97M		C-
URANIUM ENERGY CORP.	+6.72%	2.76B		B
CGN MINING COMPANY LIMITED	+17.44%	1.99B		-
YELLOW CAKE PLC	+9.22%	1.81B	-	-
BOSS ENERGY LIMITED	+28.78%	1.36B	-	D
CENTRUS ENERGY CORP.	-20.86%	689M		D+
URANIUM ROYALTY CORP.	-10.11%	280M		-
ELEVATE URANIUM LTD	+13.48%	104M	-	-
GOVIEX URANIUM INC.	-43.33%	50.2M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes